Breaking News, Financial News

Financial Report: Enzon 3Q

Product sales in the quarter were down 1% to $28.6 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Enzon 3Q09 3Q Revenues: $44.6 million (-9%) 3Q Earnings: $0.1 million (loss of $2.0 million in 3Q08) Comments: Product sales in the quarter were down 1% to $28.6 million. Contract manufacturing revenue was $2.3 million (-57%), primarily due to cancelled shipments and early discontinuation of processing for a CMO customer scheduled for termination in early 2010. Royalty revenue, for which Pegintron accounts for the majority, was $13.7 million (-6%)....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters